Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Current Pharmaceutical Design
|
March 17, 2020
New Insights on KCa3.1 Channel Modulation
Giuseppe Manfroni, Francesco Ragonese, Lorenzo Monarca, et al.
Current Pharmaceutical Design
|
April 3, 2020
Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma Therapy
Lamberto Dionigi, Francesco Ragonese, Lorenzo Monarca, et al.
Cancers
|
October 31, 2020
Effect of 1α,25(OH)<sub>2</sub> Vitamin D<sub>3</sub> in Mutant P53 Glioblastoma Cells: Involvement of Neutral Sphingomyelinase1
Samuela Cataldi, Cataldo Arcuri, Andrea Lazzarini, et al.
Biomolecules
|
March 28, 2025
High Dose C6 Ceramide-Induced Response in Embryonic Hippocampal Cells
Federico Fiorani, Martina Mandarano, Samuela Cataldi, et al.
Frontiers in Physiology
|
January 24, 2022
LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells
Concetta Caglioti, Federico Palazzetti, Lorenzo Monarca, et al.
Nutrients
|
December 20, 2018
Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability
Roberto Spogli, Maria Bastianini, Francesco Ragonese, et al.
Frontiers in Nutrition
|
August 23, 2021
Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Represents an Oral Formulation of Resveratrol With Better Gastric Absorption and Bioavailability Respect to Pure Resveratrol
Rossana Giulietta Iannitti, Alessandro Floridi, Andrea Lazzarini, et al.
International Journal of Molecular Sciences
|
May 25, 2024
Electro-Metabolic Coupling of Cumulus-Oocyte Complex
Diletta Del Bianco, Rosaria Gentile, Luana Sallicandro, et al.
Pflugers Archiv : European Journal of Physiology
|
May 19, 2026
KCa3.1 mediates radioresistance of silver nanoparticles in human glioblastoma cells
Francesco Ragonese, Andrea Biagini, Luana Sallicandro, et al.
Cancers
|
July 29, 2023
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Filomena De Falco, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Current Pharmaceutical Design
|
March 17, 2020
New Insights on KCa3.1 Channel Modulation
Giuseppe Manfroni, Francesco Ragonese, Lorenzo Monarca, et al.
Current Pharmaceutical Design
|
April 3, 2020
Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma Therapy
Lamberto Dionigi, Francesco Ragonese, Lorenzo Monarca, et al.
Cancers
|
October 31, 2020
Effect of 1α,25(OH)<sub>2</sub> Vitamin D<sub>3</sub> in Mutant P53 Glioblastoma Cells: Involvement of Neutral Sphingomyelinase1
Samuela Cataldi, Cataldo Arcuri, Andrea Lazzarini, et al.
Biomolecules
|
March 28, 2025
High Dose C6 Ceramide-Induced Response in Embryonic Hippocampal Cells
Federico Fiorani, Martina Mandarano, Samuela Cataldi, et al.
Frontiers in Physiology
|
January 24, 2022
LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells
Concetta Caglioti, Federico Palazzetti, Lorenzo Monarca, et al.
Nutrients
|
December 20, 2018
Solid Dispersion of Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Microparticles Improves Oral Bioavailability
Roberto Spogli, Maria Bastianini, Francesco Ragonese, et al.
Frontiers in Nutrition
|
August 23, 2021
Resveratrol Supported on Magnesium DiHydroxide (Resv@MDH) Represents an Oral Formulation of Resveratrol With Better Gastric Absorption and Bioavailability Respect to Pure Resveratrol
Rossana Giulietta Iannitti, Alessandro Floridi, Andrea Lazzarini, et al.
International Journal of Molecular Sciences
|
May 25, 2024
Electro-Metabolic Coupling of Cumulus-Oocyte Complex
Diletta Del Bianco, Rosaria Gentile, Luana Sallicandro, et al.
Pflugers Archiv : European Journal of Physiology
|
May 19, 2026
KCa3.1 mediates radioresistance of silver nanoparticles in human glioblastoma cells
Francesco Ragonese, Andrea Biagini, Luana Sallicandro, et al.
Cancers
|
July 29, 2023
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
Francesco Maria Adamo, Estevao Carlos Silva Barcelos, Filomena De Falco, et al.
Page
of 3